Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...
The main cause of allergic rhinitis is an exaggerated immune response to specific allergens. When the immune system encounters the allergen, it considers this substance as injurious, but in reality, ...
The JVP-led NPP government finds itself in an unenviable position. Its learning curve is disconcertingly steep. Sri Lankans are always in a hurry; patience cannot be considered one of their virtues, ...
Hantz Financial Services Inc. acquired a new position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) during the fourth quarter, according to the company in its most recent filing ...